16:30 EDT Actuate Therapeutics (ACTU) files $250M mixed securities shelf
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACTU:
- Actuate Therapeutics initiated with a Buy at B. Riley
- Actuate Therapeutics, Inc.: Strategic Regulatory Advances and Promising Clinical Data Drive Buy Rating
- Actuate, Incyte, University of Pittsburgh collaborate on elraglusib trial
- Actuate Therapeutics files to sell 1.33M shares of common stock for holders
- Promising Clinical Developments and Valuation Support Buy Rating for Actuate Therapeutics